| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.33 | 0.3 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |